Jachimska B, Goncerz M, Wolski P, Meldrum C, Lustyk L, Panczyk T
Mol Pharm. 2024; 21(11):5892-5904.
PMID: 39436101
PMC: 11539063.
DOI: 10.1021/acs.molpharmaceut.4c00941.
Szota M, Szwedowicz U, Rembialkowska N, Janicka-Klos A, Doveiko D, Chen Y
Int J Mol Sci. 2024; 25(13).
PMID: 39000306
PMC: 11241532.
DOI: 10.3390/ijms25137201.
Monta-Gonzalez G, Bastante-Rodriguez D, Garcia-Fernandez A, Lusby P, Martinez-Manez R, Marti-Centelles V
Chem Sci. 2024; 15(26):10010-10017.
PMID: 38966373
PMC: 11220577.
DOI: 10.1039/d4sc02294g.
Stachowicz-Kusnierz A, Rychlik P, Korchowiec J, Korchowiec B
Molecules. 2024; 29(11).
PMID: 38893446
PMC: 11173802.
DOI: 10.3390/molecules29112567.
Zhang L, Dong Q, Hao Y, Wang Z, Dong W, Liu Y
Adv Sci (Weinh). 2023; 10(30):e2302703.
PMID: 37697645
PMC: 10602509.
DOI: 10.1002/advs.202302703.
Upconversion Nanoparticles Intercalated in Large Polymer Micelles for Tumor Imaging and Chemo/Photothermal Therapy.
Demina P, Khaydukov K, Babayeva G, Varaksa P, Atanova A, Stepanov M
Int J Mol Sci. 2023; 24(13).
PMID: 37445751
PMC: 10342109.
DOI: 10.3390/ijms241310574.
Insights into the coordination chemistry of antineoplastic doxorubicin with 3d-transition metal ions Zn, Cu, and VO: a study using well-calibrated thermodynamic cycles and chemical interaction quantum chemistry models.
Reyna-Luna J, Soriano-Agueda L, Vera C, Franco-Perez M
J Comput Aided Mol Des. 2023; 37(7):279-299.
PMID: 37245168
DOI: 10.1007/s10822-023-00506-4.
Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer.
Marcelo G, Montpeyo D, Galhano J, Martinez-Manez R, Capelo-Martinez J, Lorenzo J
Int J Mol Sci. 2023; 24(7).
PMID: 37047582
PMC: 10095016.
DOI: 10.3390/ijms24076612.
Interactions of Nanoscale Self-Assembled Peptide-Based Assemblies with Glioblastoma Cell Models and Spheroids.
Lebedenko C, Murray M, Goncalves B, Perez D, Lambo D, Banerjee I
ACS Omega. 2023; 8(13):12124-12143.
PMID: 37033803
PMC: 10077566.
DOI: 10.1021/acsomega.2c08049.
Effect of Alkaline Conditions on Forming an Effective G4.0 PAMAM Complex with Doxorubicin.
Szota M, Jachimska B
Pharmaceutics. 2023; 15(3).
PMID: 36986735
PMC: 10057121.
DOI: 10.3390/pharmaceutics15030875.
Anomalous Properties of Cyclodextrins and Their Complexes in Aqueous Solutions.
Loftsson T, Sigurdsson H, Jansook P
Materials (Basel). 2023; 16(6).
PMID: 36984102
PMC: 10051767.
DOI: 10.3390/ma16062223.
New Nanosized Systems Doxorubicin-Amphiphilic Copolymers of -Vinylpyrrolidone and (Di)methacrylates with Antitumor Activity.
Kurmaz S, Ignatiev V, Emelyanova N, Kurmaz V, Konev D, Balakina A
Pharmaceutics. 2022; 14(12).
PMID: 36559068
PMC: 9784683.
DOI: 10.3390/pharmaceutics14122572.
Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia.
Ma W, Rousseau Z, Slavkovic S, Shen C, Yousef G, Ni H
Pharmaceuticals (Basel). 2022; 15(12).
PMID: 36558895
PMC: 9788583.
DOI: 10.3390/ph15121444.
Doxorubicin aqueous systems at low concentrations: Interconnection between self-organization, fluorescent and physicochemical properties, and action on hydrobionts.
Ryzhkina I, Murtazina L, Kostina L, Dokuchaeva I, Sergeeva S, Meleshenko K
Front Chem. 2022; 10:1063278.
PMID: 36531320
PMC: 9751371.
DOI: 10.3389/fchem.2022.1063278.
Chitosan-Boric Acid Scaffolds for Doxorubicin Delivery in the Osteosarcoma Treatment.
Dornjak L, Kovacic M, Ostojic K, Angaits A, Szpunar J, Urlic I
Polymers (Basel). 2022; 14(21).
PMID: 36365746
PMC: 9656110.
DOI: 10.3390/polym14214753.
Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer.
Marcelo G, Galhano J, Robalo T, Cruz M, Marcos M, Martinez-Manez R
Int J Mol Sci. 2022; 23(20).
PMID: 36293142
PMC: 9603674.
DOI: 10.3390/ijms232012287.
Diffusion of small molecule drugs is affected by surface interactions and crowder proteins.
Dey D, Nunes-Alves A, Wade R, Schreiber G
iScience. 2022; 25(10):105088.
PMID: 36157590
PMC: 9490042.
DOI: 10.1016/j.isci.2022.105088.
Chemo-photothermal effects of doxorubicin/silica-carbon hollow spheres on liver cancer.
Chen Y, Chiu W, Chang C, Wu P, Tu T, Lin H
RSC Adv. 2022; 8(64):36775-36784.
PMID: 35558959
PMC: 9089277.
DOI: 10.1039/c8ra08538b.
Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane.
Piorecka K, Kurjata J, Bak-Sypien I, Cypryk M, Steinke U, Stanczyk W
RSC Adv. 2022; 10(26):15579-15585.
PMID: 35495453
PMC: 9052520.
DOI: 10.1039/d0ra01319f.
An in Silico Approach to Reveal the Nanodisc Formulation of Doxorubicin.
Xu D, Chen X, Chen Z, Lv Y, Li Y, Li S
Front Bioeng Biotechnol. 2022; 10:859255.
PMID: 35284419
PMC: 8914043.
DOI: 10.3389/fbioe.2022.859255.